IDH1 and glioma: OPC-like tumours might be candidates for strategies aiming at inhibiting MYC activity such as bromodomain and extraterminal bromodomain (BET) inhibition that has been shown to suppress MYC transcriptional activity in several cancers34 and to inhibit cell growth in IDH1-mutant glioma primary cell cultures26.